Hetero-Multivalent Targeted Liposomal Drug Delivery to Treat <i>Pseudomonas aeruginosa</i> Infections-Reference-Cited by-同舟云学术

Hetero-Multivalent Targeted Liposomal Drug Delivery to Treat Pseudomonas aeruginosa Infections

Published:2022-08-26 Issue:36 Volume:14 Page:40724-40737
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Singla Akshi¹^ORCID,Simbassa Sabona B.²^ORCID,Chirra Bhagath²,Gairola Anirudh¹^ORCID,Southerland Marie R.²,Shah Kush N.²,Rose Robert E.³,Chen Qingquan²,Basharat Ahmed²,Baeza Jaime²,Raina Rohit²,Chapman Morgan J.²,Hassan Adel M.²,Ivanov Ivan⁴,Sen Anindito⁵,Wu Hung-Jen¹^ORCID,Cannon Carolyn L.²^ORCID

Affiliation:

1. Department of Chemical Engineering, Texas A&M University, College Station, Texas 77843, United States

2. Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan Texas 77807, United States

3. Comparative Medicine Program, Texas A&M University, College Station, Texas 77843, United States

4. Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843, United States

5. Microscopy and Imaging Center, Texas A&M University, College Station, Texas 77843, United States

Funder

Division of Chemistry

National Institute of Allergy and Infectious Diseases

Men of Distinction

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.2c12943

Reference70 articles.

1. Antibiotic Resistance Threats in the United States, Centers for Disease Control and Prevention; U.S. Department of Health and Human Services: Atlanta, GA, 2019.

2. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist1*Address for correspondence: Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA

3. The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections

4. Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015

5. Surgical Site Infection Event (SSI), Centers for Disease Control and Prevention; National Healthcare Safety Network, 2022.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends;Journal of Controlled Release;2024-09

2. Strategies to Promote the Journey of Nanoparticles Against Biofilm‐Associated Infections;Small;2024-01-04

3. Polymyxin B-Modified Fosfomycin Liposomes Target Gram-Negative Bacteria and Exert Synergistic Antibacterial Effect;ACS Omega;2023-11-22

4. Innovative Phospholipid Carriers: A Viable Strategy to Counteract Antimicrobial Resistance;International Journal of Molecular Sciences;2023-11-03

5. Nanomedicine to overcome antimicrobial resistance: challenges and prospects;Nanomedicine;2023-02